The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investee Company Update: Yooma Corp.

26 Jan 2021 14:14

RNS Number : 9539M
FastForward Innovations Limited
26 January 2021
 

FastForward Innovations Ltd / AIM: FFWD / Sector: Closed End Investments

26 January 2021

FastForward Innovations Ltd ("FastForward" or, "FFWD")

Investee Company Update: Yooma Corp.

 

FastForward Innovations Ltd, the AIM quoted company focusing on making investments in fast growing and industry leading businesses, is pleased to confirm the merger of Yooma Corp. ('Yooma'), in which it holds a 10.65% interest, and Globalive Technology (TSX-V: LIVE) ('Globalive') has been approved at a special meeting of its shareholders.

 

Following completion of the merger, which remains subject to Canadian regulatory approval, FFWD will hold 4,007,165 shares in Globalive representing 8.95% of the enlarged issued share capital.

 

Ed McDermott, CEO of FastForward, commented: "We are delighted that the merger between Yooma and Globalive has been approved. To see a liquidity event for our holding in Yooma within less than a year from our investment is a great result and one we hope can be replicated across other portfolio companies over the next 12 months. We are very excited to see the combined forces of Globalive and Yooma continue to expand their business plan as a public company and the resulting value that this could bring to FastForward as a shareholder."

 

The announcement is set out below without material changes or adjustments.

 

Globalive Technology Announces Results of Shareholder Meeting on January 25, 2021

 

TORONTO, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Globalive Technology (TSX-V: LIVE) (the "Company"), a technology firm based in Toronto, Ontario, held a special meeting of its shareholders (the "Meeting") on January 25, 2021 at 10:00 a.m. (Toronto time).

 

The Company is pleased to announce that each of the resolutions proposed in the management information circular for the Meeting (the "Circular") were approved by the shareholders of the Company, including:

(i)

Authorization to implement a plan of arrangement to complete a reverse takeover transaction with Yooma Corp. on substantially the terms described in the Circular (the "RTO Transaction").

 

 

(ii)

Authorization to apply to have the Company de-listed from the TSX Venture Exchange in connection with the completion of the RTO Transaction.

 

 

(iii)

Authorization for a new long term incentive plan, that will be the go-forward incentive plan for the resulting issuer of the RTO Transaction.

Additional details about the Meeting, the resolutions approved by the shareholders and other matters pertaining to the RTO Transaction can be found in the Circular, and in supplementary press releases issued by the Company on January 18, 2021 and January 20, 2021, all of which are available on the Company's SEDAR page at www.sedar.com .

 

The Company notes that the business of the Meeting remains subject to final approval by the TSX Venture Exchange and the Canadian Securities Exchange.

 

ABOUT GLOBALIVE TECHNOLOGY

Globalive Technology is a next generation software company and venture partner that is developing and investing in innovative solutions to disrupt traditional industries. The company forms partnerships with leading high growth companies to develop and commercialize software solutions using optimal technology stacks. It is controlled by Globalive Capital Inc., which has founded and co-founded 12 businesses over the past 20 years with six successful exits ranging from $10M to $1.3B USD, has made over 100 venture investments and has over 45 technology companies in its portfolio. For more information, visit www.globalivetech.com.

 

CAUTION REGARDING FORWARD-LOOKING INFORMATION

This news release contains forward-looking statements relating to the Company and its proposed reverse takeover transaction with Yooma Corp. Such forward-looking statements are identified by terms such as "to apply", "will be", "remain subject to" and similar expressions. All statements, other than statements of historical fact included in this release, including those noted above, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company's expectations include the Company being unable to obtain final TSX Venture Exchange or Canadian Securities Exchange approvals for any items of business proposed at the Meeting, the Company or its reverse takeover transaction partner determining not to proceed with the transaction or being unable to satisfy the closing conditions for such transaction, the Company or its transaction partner proposing amendments to the long term incentive plan or determining not to proceed with the implementation of the long term incentive plan, and other risks as set out in the Company's management information circular for the Meeting dated December 21, 2020 and its supplementary press releases dated January 18, 2021 and January 20, 2021, all of which are available on its SEDAR page at www.sedar.com.

 

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The Company cannot guarantee that any of the forward-looking statements contained in this press release will occur as disclosed herein or at all. The reader is cautioned not to place undue reliance on any forward-looking information.

 

Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law.

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

 

For media inquiries:Rob MoyseyCommunications Manager, GlobaliveMedia@globalivetech.com

 

For investor inquiries:Simon LockieChief Corporate Officer1-647-977-2727InvestorRelations@globalivetech.com

 

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

 

ENDS

 

For further information on the Company please visit www.fstfwd.co or contact:

Ed McDermott / Lance de Jersey

FastForward Innovations Ltd

E: info@fstfwd.co

 

James Biddle / Roland Cornish

Beaumont Cornish Limited,

Nomad

 

T: +44 (0)20 7628 3396

 

Isabella Pierre / Damon Heath

Shard Capital Partners LLP

 

T: +44 (0)20 7186 9927

Isabel de Salis / Beth Melluish

St Brides Partners Ltd,

Financial PR

E: info@stbridespartners.co.uk

 

Notes

FastForward Innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early-stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCZQLFLFFLBBBK
Date   Source Headline
25th Feb 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
18th Feb 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
11th Feb 20207:00 amRNSUpdated Key Information Document
31st Jan 20201:30 pmRNSInvestee Company Update: Portage Biotech Inc.
8th Jan 20207:00 amRNSDisposal of Interest in Cryptologic Corp
7th Jan 20207:00 amRNSBoard Appointment
3rd Jan 20201:15 pmRNSInvestee Company Update: Portage Biotech Inc.
11th Dec 20197:00 amRNSHalf-year Report
5th Dec 20192:45 pmRNSTR-1 Notification
19th Nov 20197:00 amRNSLorne Abony appointed as Chairman of EMMAC
16th Oct 20197:00 amRNSInvestee Company Update: EMMAC Life Sciences
15th Oct 20197:00 amRNSInvestee Company Update: Factom inc.
10th Oct 20199:25 amRNSResult of 2019 AGM
27th Sep 20194:31 pmRNSDirector Dealing in the Company
27th Sep 20197:00 amRNSInvestee Company Update : Fralis LLC (Leap Gaming)
26th Sep 201911:21 amRNSInvestee Company Update : Cryptologic Corp
16th Sep 201911:52 amRNSTR-1 Notification of major holdings
11th Sep 20198:00 amRNSResults for the year ended 31st March 2019
11th Sep 20198:00 amRNSNotice of 2019 Annual General Meeting
22nd Aug 201912:01 pmRNSDirectorate Change
19th Aug 20199:23 amRNSJuvenescence closes Series B funding
12th Aug 20193:02 pmRNSInvestee Company Update-Cryptologic issues loan
12th Aug 201910:11 amRNSPortage Trading Suspended
6th Aug 20194:42 pmRNSInvestee Company Update: Cryptologic Corp
30th Jul 201911:07 amRNSSAFE Agreement with Factom, Inc. Extended
25th Jul 20198:17 amRNSFactom Inc SAFE Agreement temporary extension
18th Jul 201911:20 amRNSInvestee Company Update: Regent Pacific on Yooya
16th Jul 20199:13 amRNSInvestee Company Update:EMMAC acquires Terre Verde
11th Jul 20193:00 pmRNSDisposal of interest in Intensity Therapeutics Inc
9th Jul 201910:51 amRNSInvestee Company Update: EMMAC enters new Market
26th Jun 20198:56 amRNSInvestee Company Update: Intensity Therapeutics
29th May 20193:43 pmRNSInvestee Company Update: Offer for Yooya
13th May 201910:21 amRNSDisposal of interest in Vemo Education Inc.
18th Apr 20197:00 amRNSInvestee Company Update: Intensity Therapeutics
4th Apr 20199:51 amRNSTR1 - Correction
3rd Apr 20194:00 pmRNSTR:1 Regent Mercantile Holdings Limited
20th Mar 201911:00 amRNSCompletion of £2 million investment in EMMAC
7th Mar 20194:03 pmRNS£2 million investment in EMMAC Life Sciences
15th Jan 20193:45 pmRNSJuvenescence Series B Funding
3rd Jan 201911:47 amRNSBoard Appointment
12th Dec 201812:52 pmRNSHalf-year Report
3rd Dec 20187:00 amRNSInvestee Company Update: Factom and Yooya
14th Nov 20181:31 pmRNSInvestee Company Update: Factom Inc
22nd Oct 201812:24 pmRNSIntensity Therapeutics Inc Update
12th Sep 20186:12 pmRNSResult of AGM
10th Sep 20189:16 amRNSHolding(s) in Company
22nd Aug 20188:08 amRNSDirector Dealing
3rd Aug 201812:48 pmRNSShareholder update
3rd Aug 20188:00 amRNSPlacing
1st Aug 201812:05 pmRNSResponse to Media Speculation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.